Research Article
BibTex RIS Cite

Elastofibroma Dorsi: Tek Merkez Deneyimi

Year 2021, Volume: 74 Issue: 2, 264 - 268, 31.08.2021

Abstract

Amaç: Elastofibroma dorsi nedeniyle opere edilen hastalarımızda tanı, takip, cerrahi tedavi ve sonuçları konusundaki deneyimlerimizi ortaya koymayı amaçladık.

Gereç ve Yöntem: Cerrahi rezeksiyon uygulanan elastofibroma dorsi tanılı 25 hastanın verileri retrospektif olarak incelendi. Yaş, cinsiyet, taraf, semptom, özgeçmiş, meslek, boyut, dren takip zamanı ve postoperatif komplikasyonlar analiz edildi. Hastalar ayrıca patoloji raporunda yer alan lezyon boyutlarının üçünün (en, boy, yükseklik) çarpımı sonucu elde edilen hacim baz alınarak, <200 cm3 (Grup 1) ve 200 cm3≤ (Grup 2) olarak 2 gruba ayrıldı.

Bulgular: Ortalama yaş 54,62±7,02 idi. Yirmi bir hastanın 4’ü (%19) erkek, 17’si (%81) kadındı. On bir (%52,4) kişi ev hanımı, 6 (%28,6) kişi işçi idi, 4 (%19) kişi kol kuvveti gerektirmeyen meslek yapmaktaydı. Lezyon hacim artışı ile dren sonlandırma zamanı arasında istatistiksel olarak anlamlı olmayan (p=0,563, r=0,134) doğru orantı vardı. Hiçbir hastamızda nüks gözlenmedi. Hiçbir hastamızda ağrı dışında postoperatif komplikasyon gözlenmedi.

Sonuç: Semptomatik elastofibroma dorsi olgularının tedavisinde total cerrahi rezeksiyon etkili ve yeterli bir tedavi yöntemidir.

Ethical Statement

Etik Kurul Onayı: Kocaeli Üniversitesi Tıp Fakültesi Girişimsel Olmayan İşlemler Etik Kurulu’nun 02.12.2020 tarih ve 2020/336 sayılı onayı alındı. Hasta Onayı: Operasyon öncesi hastalardan onay alınmıştır. Hakem Değerlendirmesi: Editörler kurulunun dışından olan kişiler tarafından değerlendirilmiştir.

Supporting Institution

-

Project Number

-

Thanks

-

References

  • 1. Yenigün BM, Yildiz O, Yüksel C, et al. Elastofibroma dorsi: 11 olgunun analizi ve literatürün gözden geçirilmesi [Elastofibroma dorsi: report of 11 cases analysis and review of the literature]. Tuberk Toraks. 2014;62:85-88.
  • 2. Kuzucuoğlu M. Göğüs Duvarının Nadir Görünen Tümörü; Elastofibroma Dorsi. Balıkesir Sağlık Bilimleri Dergisi. 2017;6:75-78.
  • 3. Köksel O, Özgülder A, Özer C, et al. Elastofibroma Dorsi: Olgu Sunumu. Türk Gö¤üs Kalp Damar Cerrahisi Dergisi. 2005;13:279-282.
  • 4. Deveci MA, Özbarlas HS, Erdoğan KE, et al. Elastofibroma dorsi: Clinical evaluation of 61 cases and review of the literature. Acta Orthop Traumatol Turc. 2017;51:7-11.
  • 5. Bartocci M, Dell’Atti C, Meacci E, et al. Clinical features, imaging findings, treatment aspects of elastofibroma dorsi and long-term outcomes after surgical resection. Eur Rev Med Pharmacol Sci. 2017;21:2061-2068.
  • 6. Criscione A, Palmucci S, Calvo D, et al. Elastofibroma dorsi and the thoracic surgeon: experience with 13 patients. Future Oncol. 2015;11(24 Suppl):47-50.
  • 7. Sahin M, Gul VO. Is it necessary to always resect elastofibroma dorsi? ANZ J Surg. 2020 Dec 1.
  • 8. Di Vito A, Scali E, Ferraro G, et al. Elastofibroma dorsi: a histochemical and immunohistochemical study. Eur J Histochem. 2015;59:2459.
  • 9. Tepe M, Polat MA, Calisir C, et al. Prevalence of elastofibroma dorsi on CT: Is it really an uncommon entity? Acta Orthop Traumatol Turc. 2019;53:195- 198.
  • 10. Yarıkkaya E, Sayılgan AT, Özcan D. Elastofibromda Tru-Cut Biyopsinin Rolü:5 Olgu. Haseki Tıp Bulteni. 2012;50:146-149.
  • 11. Oliva MS, Smimmo A, Vitiello R, et al. Elastofibroma dorsi: What’s new? Orthop Rev (Pavia). 2020;12(Suppl 1):8708.
  • 12. Scamporlino A, Ruggiero C, Aramini B, et al. Surgery for elastofibroma dorsi: optimizing the management of a benign tumor-an analysis of 70 cases. J Thorac Dis. 2020;12:1884-1894.
  • 13. Cinar BM, Akpinar S, Derincek A, et al. Elastofibroma dorsi: Nadir görülen bir omuz ağrisi nedeni [Elastofibroma dorsi: an unusual cause of shoulder pain]. Acta Orthop Traumatol Turc. 2009;43:431-435.
  • 14. Başaran C, Dönmez FY, Öztürk A, et al. Elastofibroma Dorsi’de MRG Bulguları. Fırat Tıp Dergisi. 2009;14:65-68.
  • 15. Tsubakimoto M, Yamashiro T, Tsuchiya N, et al. MRI findings and demographics of elastofibroma dorsi: assessment of diffusion-weighted imaging and contrast enhancement patterns. Acta Radiol. 2018;59:709- 715.
  • 16. Minarro JC, Urbano-Luque MT, López-Jordan A, et al. The comparison of measurement accuracy among three different imaging modalities in evaluating elastofibroma dorsi. An analysis of 52 cases. Int Orthop. 2015;39:1145-1149.
  • 17. Fang N, Wang YL, Zeng L, et al. Characteristics of elastofibroma dorsi on PET/CT imaging with (18)F-FDG. Clin Imaging. 2016;40:110-113.
  • 18. Ishiyama M, Vesselle H. 68Ga DOTATATE PET/CT Imaging of Elastofibroma Dorsi. Clin Nucl Med. 2018;43:154-155.
  • 19. Oporto M, Cepa F, Orta N, et al. Fibroelastic pseudotumor elastofibroma dorsi detected by 18F-FDG PET/CT scan and by postherapy radioiodine SPECT/CT. Rev Esp Med Nucl Imagen Mol. 2018;37:46-49.
  • 20. Keskin H. Nadir Görülen Elastofibroma Dorsi’de Klinik Deneyimimize Dayanarak Tanı Ve Tedavi Algoritması Oluşturulması. Bozok Tıp Derg. 2018;8:18-24.
  • 21. Nagano S, Yokouchi M, Setoyama T, et al. Elastofibroma dorsi: Surgical indications and complications of a rare soft tissue tumor. Mol Clin Oncol. 2014;2:421-424.

Elastofibroma Dorsi: Single Center Experience

Year 2021, Volume: 74 Issue: 2, 264 - 268, 31.08.2021

Abstract

Objectives: We aimed to reveal our experience in diagnosis, follow-up, surgical treatment and results in our patients who were operated for elastofibroma dorsi.

Materials and Methods: The data of 25 patients diagnosed with elastofibroma dorsi, who underwent surgical resection, were retrospectively evaluated. Age, gender, side, symptom, disease history, job, size, drain follow-up time and postoperative complications were analyzed. The patients were also divided into 2 groups as <200 cm3 (Group 1) and 200 cm3≤ (Group 2) based on the volume obtained by multiplying three (width, height, height) of the lesion sizes in the pathology report.

Results: The mean age was 54.62±7.02 years. 4 (19%) of 21 patients were male, 17 (81%) were female. Eleven (52.4%) people were housewives, 6 (28.6%) people were workers, 4 (19%) people were doing professions not requiring manual force. There was a non-statistically significant (p=0.563,r=0.134) direct proportion between lesion volume increase and drain termination time. No recurrence was observed in any of our patients. No postoperative complications were observed in any of our patients, except pain.

Conclusion: Total surgical resection is an effective and sufficient treatment method in the treatment of symptomatic cases of elastofibroma dorsi.

Project Number

-

References

  • 1. Yenigün BM, Yildiz O, Yüksel C, et al. Elastofibroma dorsi: 11 olgunun analizi ve literatürün gözden geçirilmesi [Elastofibroma dorsi: report of 11 cases analysis and review of the literature]. Tuberk Toraks. 2014;62:85-88.
  • 2. Kuzucuoğlu M. Göğüs Duvarının Nadir Görünen Tümörü; Elastofibroma Dorsi. Balıkesir Sağlık Bilimleri Dergisi. 2017;6:75-78.
  • 3. Köksel O, Özgülder A, Özer C, et al. Elastofibroma Dorsi: Olgu Sunumu. Türk Gö¤üs Kalp Damar Cerrahisi Dergisi. 2005;13:279-282.
  • 4. Deveci MA, Özbarlas HS, Erdoğan KE, et al. Elastofibroma dorsi: Clinical evaluation of 61 cases and review of the literature. Acta Orthop Traumatol Turc. 2017;51:7-11.
  • 5. Bartocci M, Dell’Atti C, Meacci E, et al. Clinical features, imaging findings, treatment aspects of elastofibroma dorsi and long-term outcomes after surgical resection. Eur Rev Med Pharmacol Sci. 2017;21:2061-2068.
  • 6. Criscione A, Palmucci S, Calvo D, et al. Elastofibroma dorsi and the thoracic surgeon: experience with 13 patients. Future Oncol. 2015;11(24 Suppl):47-50.
  • 7. Sahin M, Gul VO. Is it necessary to always resect elastofibroma dorsi? ANZ J Surg. 2020 Dec 1.
  • 8. Di Vito A, Scali E, Ferraro G, et al. Elastofibroma dorsi: a histochemical and immunohistochemical study. Eur J Histochem. 2015;59:2459.
  • 9. Tepe M, Polat MA, Calisir C, et al. Prevalence of elastofibroma dorsi on CT: Is it really an uncommon entity? Acta Orthop Traumatol Turc. 2019;53:195- 198.
  • 10. Yarıkkaya E, Sayılgan AT, Özcan D. Elastofibromda Tru-Cut Biyopsinin Rolü:5 Olgu. Haseki Tıp Bulteni. 2012;50:146-149.
  • 11. Oliva MS, Smimmo A, Vitiello R, et al. Elastofibroma dorsi: What’s new? Orthop Rev (Pavia). 2020;12(Suppl 1):8708.
  • 12. Scamporlino A, Ruggiero C, Aramini B, et al. Surgery for elastofibroma dorsi: optimizing the management of a benign tumor-an analysis of 70 cases. J Thorac Dis. 2020;12:1884-1894.
  • 13. Cinar BM, Akpinar S, Derincek A, et al. Elastofibroma dorsi: Nadir görülen bir omuz ağrisi nedeni [Elastofibroma dorsi: an unusual cause of shoulder pain]. Acta Orthop Traumatol Turc. 2009;43:431-435.
  • 14. Başaran C, Dönmez FY, Öztürk A, et al. Elastofibroma Dorsi’de MRG Bulguları. Fırat Tıp Dergisi. 2009;14:65-68.
  • 15. Tsubakimoto M, Yamashiro T, Tsuchiya N, et al. MRI findings and demographics of elastofibroma dorsi: assessment of diffusion-weighted imaging and contrast enhancement patterns. Acta Radiol. 2018;59:709- 715.
  • 16. Minarro JC, Urbano-Luque MT, López-Jordan A, et al. The comparison of measurement accuracy among three different imaging modalities in evaluating elastofibroma dorsi. An analysis of 52 cases. Int Orthop. 2015;39:1145-1149.
  • 17. Fang N, Wang YL, Zeng L, et al. Characteristics of elastofibroma dorsi on PET/CT imaging with (18)F-FDG. Clin Imaging. 2016;40:110-113.
  • 18. Ishiyama M, Vesselle H. 68Ga DOTATATE PET/CT Imaging of Elastofibroma Dorsi. Clin Nucl Med. 2018;43:154-155.
  • 19. Oporto M, Cepa F, Orta N, et al. Fibroelastic pseudotumor elastofibroma dorsi detected by 18F-FDG PET/CT scan and by postherapy radioiodine SPECT/CT. Rev Esp Med Nucl Imagen Mol. 2018;37:46-49.
  • 20. Keskin H. Nadir Görülen Elastofibroma Dorsi’de Klinik Deneyimimize Dayanarak Tanı Ve Tedavi Algoritması Oluşturulması. Bozok Tıp Derg. 2018;8:18-24.
  • 21. Nagano S, Yokouchi M, Setoyama T, et al. Elastofibroma dorsi: Surgical indications and complications of a rare soft tissue tumor. Mol Clin Oncol. 2014;2:421-424.
There are 21 citations in total.

Details

Primary Language English
Subjects Thoracic Surgery
Journal Section Research Article
Authors

Hüseyin Fatih Sezer 0000-0001-5812-7088

Aykut Elicora 0000-0002-9565-0692

Salih Topcu This is me 0000-0002-0382-2881

Galbinur Abdullayev 0000-0002-3328-7381

Project Number -
Publication Date August 31, 2021
Published in Issue Year 2021 Volume: 74 Issue: 2

Cite

APA Sezer, H. F., Elicora, A., Topcu, S., Abdullayev, G. (2021). Elastofibroma Dorsi: Single Center Experience. Ankara Üniversitesi Tıp Fakültesi Mecmuası, 74(2), 264-268. https://doi.org/10.4274/atfm.galenos.2021.73792
AMA Sezer HF, Elicora A, Topcu S, Abdullayev G. Elastofibroma Dorsi: Single Center Experience. Ankara Üniversitesi Tıp Fakültesi Mecmuası. August 2021;74(2):264-268. doi:10.4274/atfm.galenos.2021.73792
Chicago Sezer, Hüseyin Fatih, Aykut Elicora, Salih Topcu, and Galbinur Abdullayev. “Elastofibroma Dorsi: Single Center Experience”. Ankara Üniversitesi Tıp Fakültesi Mecmuası 74, no. 2 (August 2021): 264-68. https://doi.org/10.4274/atfm.galenos.2021.73792.
EndNote Sezer HF, Elicora A, Topcu S, Abdullayev G (August 1, 2021) Elastofibroma Dorsi: Single Center Experience. Ankara Üniversitesi Tıp Fakültesi Mecmuası 74 2 264–268.
IEEE H. F. Sezer, A. Elicora, S. Topcu, and G. Abdullayev, “Elastofibroma Dorsi: Single Center Experience”, Ankara Üniversitesi Tıp Fakültesi Mecmuası, vol. 74, no. 2, pp. 264–268, 2021, doi: 10.4274/atfm.galenos.2021.73792.
ISNAD Sezer, Hüseyin Fatih et al. “Elastofibroma Dorsi: Single Center Experience”. Ankara Üniversitesi Tıp Fakültesi Mecmuası 74/2 (August2021), 264-268. https://doi.org/10.4274/atfm.galenos.2021.73792.
JAMA Sezer HF, Elicora A, Topcu S, Abdullayev G. Elastofibroma Dorsi: Single Center Experience. Ankara Üniversitesi Tıp Fakültesi Mecmuası. 2021;74:264–268.
MLA Sezer, Hüseyin Fatih et al. “Elastofibroma Dorsi: Single Center Experience”. Ankara Üniversitesi Tıp Fakültesi Mecmuası, vol. 74, no. 2, 2021, pp. 264-8, doi:10.4274/atfm.galenos.2021.73792.
Vancouver Sezer HF, Elicora A, Topcu S, Abdullayev G. Elastofibroma Dorsi: Single Center Experience. Ankara Üniversitesi Tıp Fakültesi Mecmuası. 2021;74(2):264-8.